FDA credit card use subject of HHS Inspector General audit.
This article was originally published in The Rose Sheet
Executive Summary
HHS INSPECTOR GENERAL TO AUDIT FDA CREDIT CARD USE IN FY 1997, according to an IG work plan for the 12 months ending Sept. 30, 1997. The HHS Office of the Inspector General says it plans to take a look at "FDA's management controls related to credit cards used for small purchases under $2,500."